Asia Pacific Cell & Gene Therapy Excellence Awards 2023

Asia Pacific CGT Excellence Awards 2023 seeks to give recognition to exceptional Cell & Gene Therapy Pioneers, Researchers, Innovators & Manufacturers that facilitate fast advancement in new therapies, R&D and manufacturing. Featuring top Cell & Gene Therapy leaders in the industry, along with the new cell & gene therapy research development, latest advances and technologies and best practices in Cell & Gene manufacturing, the Asia Pacific CGT Excellence Awards 2023 applauds extraordinary leaders & trend-setters of today and inspires innovators of tomorrow.
The Awards Ceremony will be held in conjunction with 7th Annual Cell & Gene Therapy World Asia 2023, in-person on the 13th September 2023, in Singapore.
How does it work?
IMAPAC, the organizing committee of APCGTEA 2023 will call for nominations from the IMAPAC CGT community for different CGT award categories. Based on the number of nominations and assessment, the top 5 entries under each category were shortlisted. From the top 5 entries, the award winner will be determined by 100 % voting results from the public or CGT community. Based on the number of nominations and assessment, the top 5 entries under each category were shortlisted. From the top 5 entries, the award winner will be determined by 100 % voting results from the public or the CGT community.
TIMELINE OF AWARDS
Nominations Open
Nominations Closed and Final nominees shortlisted for all award categories
Final nominees shortlisted for all award categories
Public Voting Open
Public Voting closed
Awards winners notified
APBCEA 2023 Award Ceremony
Criteria for nomination
THE CRITERIA FOR A COMPANY TO BE ELIGIBLE FOR THE ASIA PACIFIC CELL & GENE THERAPY EXCELLENCE AWARDS 2023 ARE:
- The company should be an organization that is involved in cell & gene therapy development and/or manufacturing
- The company should have a notable presence in APAC
- The company should have displayed significant developments in the past few years
CRITERIA TO WIN THE AWARDS
Based on the number of nominations and assessment, the top 5-7 entries under each category were shortlisted. From the top 5-7 entries, the award winner will be determined by 100 % voting results from the Cell & Gene Therapy community. Companies with the most number of votes will win the award in their respective category.
Award Categories open for nominations

Best Cell & Gene Therapy Supplier Award – Clinical Trials

Best Cell & Gene Therapy Supplier Award: Upstream Processing

Best Cell & Gene Therapy Supplier Award: Upstream Processing

Overall Best Cell & Gene Therapy Supplier Award
